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Background: Homeostasis within mammalian cells is achieved through complex molecular networks that can
respond to changes within the cell or the environment and regulate the expression of the appropriate genes in
response. The development of biological components that can respond to changes in the cellular environment and
interface with endogenous molecules would enable more sophisticated genetic circuits and greatly advance our
cellular engineering capabilities.
Results: Here we describe a platform that combines a ligand-responsive ribozyme switch and synthetic miRNA
regulators to create an OFF genetic control device based on RNA interference (RNAi). We developed a mathematical
model to highlight important design parameters in programming the quantitative performance of RNAi-based OFF
control devices. By modifying the ribozyme switch integrated into the system, we demonstrated RNAi-based OFF
control devices that respond to small molecule and protein ligands, including the oncogenic protein E2F1. We
utilized the OFF control device platform to build a negative feedback control system that acts as a proportional
controller and maintains target intracellular protein levels in response to increases in transcription rate.
Conclusions: Our work describes a novel genetic device that increases the level of silencing from a miRNA in the
presence of a ligand of interest, effectively creating an RNAi-based OFF control device. The OFF switch platform has
the flexibility to be used to respond to both small molecule and protein ligands. Finally, the RNAi-based OFF switch
can be used to implement a negative feedback control system, which maintains target protein levels around a set
point level. The described RNAi-based OFF control device presents a powerful tool that will enable researchers to
engineer homeostasis in mammalian cells.
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The complexity of mammalian cells is largely due to the so-
phisticated control mechanisms employed to modulate the
expression of endogenous genes [1]. Molecules in the cell
are organized into networks, which can respond to changes
in intracellular protein or metabolite levels, as well as
changes in the environment, by upregulating or downregu-
lating the expression of any number of genes [1]. These
genetic circuits are essential for virtually all cellular pro-
cesses including differentiation [2], replication [3], and sig-
nal transduction [4]. The ability to interface with these
endogenous programs to create novel molecular networks
would greatly advance our cellular engineering capabilities
for a variety of applications. Central to our ability to create* Correspondence: csmolke@stanford.edu
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unless otherwise stated.these new genetic circuits is the development of biological
components that can respond to changes in the cellular en-
vironment and interface with endogenous molecules to en-
able more sophisticated synthetic circuits [5].
MicroRNAs (miRNA) are a class of small regulatory
RNAs that are used to post-transcriptionally control gene
expression in higher eukaryotes [6]. MiRNA biogenesis be-
gins with longer pri-miRNAs, which are cleaved by a Micro-
processor complex into shorter ~60 nucleotide pre-miRNA
hairpins and subsequently exported from the nucleus. The
pre-miRNA is subject to a final cleavage step in the cyto-
plasm by the enzyme Dicer, which creates a 22–25 nucleo-
tide (nt) double stranded RNA [7]. One of these RNA
strands, called the guide strand, is then incorporated into
one of the Argonaut family of proteins to create the RNA-
induced silencing complex (RISC). This complex subse-
quently cleaves or translationally represses the targetThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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between the miRNA and the target [6]. This powerful mech-
anism of gene regulation plays vital roles in diverse pro-
cesses, such as development and angiogenesis, and it is
estimated that RNAi regulates the majority of genes in the
human genome [8].
RNA-based synthetic biology tools are powerful re-
sources for building synthetic control systems that can
detect and respond to changes in cell state or the cellu-
lar environment, and synthetic RNA-based systems have
been demonstrated in mammalian cells [9-12]. Frame-
works have been described for the design of miRNA-
and shRNA-based molecular switches, whose biogenesis
is responsive to changes in concentration of intracellular
ligand molecules [13]. In general, these regulators are
constructed by coupling the binding of a ligand to an
RNA aptamer with the proper formation and biogenesis
of the RNAi element [13]. The physical coupling of the
aptamer to the RNAi element has been accomplished in
several ways. Researchers have directly coupled an apta-
mer to a pri-miRNA, such that binding of the ligand to
the aptamer sterically inhibits proper biogenesis by the
Microprocessor [13]. Both direct coupling and strand
displacement mechanisms have been described, where
ligand binding to the aptamer changes the structure of
an shRNA such that it is unable to be properly proc-
essed by Dicer [14,15].
These RNAi-based control systems are particularly
useful for imparting conditional silencing over endogen-
ous genes. Previously, we developed a computational
model that predicts target gene expression levels result-
ing from synthetic circuits based on miRNA regulatory
components [16]. This model was applied to direct the
rational design of miRNA-based genetic circuits and
supported an in-vivo protein concentration detector cir-
cuit by providing a quantitative relationship between
target reporter and protein ligand levels in the cell.
However, the designs in this previous work utilize a
switch architecture that inhibits RNAi-based gene silen-
cing in the presence of the ligand, thereby increasing tar-
get gene expression as a function of increasing ligand
concentration and operating as ON switches. An RNAi-
based control platform that can be used to decrease the
expression of a target gene in response to increasing
concentrations of proteins of interest has not been de-
scribed. However, this type of OFF switch regulation is
essential for building core control strategies such as
negative feedback control. Negative feedback is a preva-
lent control mechanism found in diverse biological sys-
tems, such as bacterial chemotaxis [17] and vision [18],
that can be utilized to achieve homeostasis.
Here we describe and characterize an OFF genetic control
device based on RNAi that combines a ligand-responsive
ribozyme switch and synthetic miRNA regulators. Thedevice architecture links ribozyme cleavage to miRNA
levels, such that ligand binding modulates ribozyme cleavage
rates and thus miRNA-based gene silencing. The system
was prototyped using a previously described theophylline-
responsive ribozyme switch and a miRNA that targets a
fluorescent reporter. A mathematical model of this system
was developed to highlight important design parameters in
programming the quantitative performance of RNAi-based
OFF control devices. We demonstrated RNAi-based OFF
control devices that respond to protein ligands by incorpor-
ating protein-responsive ribozyme switches to E2F1 and
MS2. We utilized the OFF control device platform to build
a negative feedback control system that maintains target
intracellular protein levels around a set point. The negative
feedback control system acts as a proportional controller,
maintaining target intracellular protein levels in response to
increases in transcription rate. The described RNAi-based
OFF control device presents a powerful tool that will enable
researchers to engineer homeostasis into mammalian cells,
for example, to maintain a desired phenotype even in the
presence of genetic mutations or fluctuating levels of signal-
ing molecules or cytokines.
Results and discussion
A trans-acting genetic device that exhibits OFF control by
coupling ribozyme switches and miRNAs
We developed a strategy to implement a gene-regulatory
device that exhibits OFF control in the regulation of en-
dogenous gene targets. Our platform design is inspired
by a mechanism found in natural miRNA clusters, where
cleavage of a transcript in a region upstream of a pri-
miRNA reduces the steady-state level of the transcript
encoding the pri-miRNA and thus the resulting gene
silencing due to the processed miRNA [19]. We hypoth-
esized that by imparting conditional cleavage of a tran-
script in a region upstream of a pri-miRNA by using a
ligand-responsive ribozyme we could control the level of
silencing from the encoded miRNA (Figure 1). In the
proposed system design, the ribozyme cleaves in the ab-
sence of ligand, thereby reducing the steady-state level
of the pri-miRNA transcript and resulting in reduced
miRNA-based silencing and increased target gene ex-
pression. However, when bound to the ligand the ribo-
zyme’s cleavage rate is substantially reduced, such that
higher steady-state levels of the pri-miRNA transcript
will accumulate and be processed, resulting in reduced
expression of the target gene.
We used a modular ligand-responsive ribozyme switch
platform that supports efficient tailoring of RNA device
function [20]. The ribozyme switch platform specifies phys-
ical linkages between three functional RNA components: a
sensor encoded by an RNA aptamer, an actuator encoded
by a hammerhead ribozyme, and a transmitter encoded by
a sequence that undergoes a strand-displacement event
Figure 1 Schematic of the RNAi-based OFF control device architecture. A catalytic ribozyme switch is placed upstream of a pri-miRNA in the same
expression cassette. (a) In the absence of the input ligand, the ribozyme switch cleaves once it is transcribed, aborting transcription such that the miRNA is
not be transcribed, thereby resulting in high target gene expression levels. (b) In the presence of ligand, ribozyme cleavage is inhibited such that transcription
proceeds through the pri-miRNA, which undergoes proper miRNA biogenesis. Target expression levels are lowered due to miRNA silencing.
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ribozyme design makes it relatively straightforward to mod-
ify the ligand-responsiveness of the switch by swapping in
new aptamer sequences into the sensor component of the
platform while maintaining the overall activity of the
switch.
An expression cassette for the device was designed based
on placing a ligand-responsive ribozyme upstream of a clus-
ter of three identical GFP-targeting miRNAs (Figure 2a).
The miRNA guide strands were designed to be completely
complementary to the target transcript, such that their
mechanism of gene silencing reflects that of an siRNA
although they are processed from a primary transcript
through the endogenous miRNA pathway [13]. The
device was prototyped with a previously characterized
theophylline-responsive ribozyme that was shown to
exhibit a reduced cleavage rate as a function of increas-
ing theophylline concentration [21]. Three versions of
the OFF control device were designed in which the
spacer length between the ribozyme and miRNA compo-
nents was varied (500, 1500, 2500 bp) to examine the effect
of spacer length on device performance. Control constructs
were developed that had the theophylline-responsive
ribozyme replaced with a non-cleaving ribozyme or that
removed the miRNAs from the expression cassette
(Additional file 1: Figure S2). A second expression cassette
was constructed that encoded the expression of a GFP
fluorescent reporter protein. Isogenic cell lines stably ex-
pressing both expression cassettes were generated from a
Flp-In HEK293 cell line by co-transfecting a plasmidharboring both expression cassettes with a plasmid that ex-
presses a Flp recombinase (pOG44) and selecting for stable
integrants.
Device performance was quantified by measuring tar-
get protein (GFP) and mature miRNA levels in the pres-
ence and absence of ligand (Figure 2b, c). GFP levels
were measured using a flow cytometry assay and mature
miRNA levels were measured using a qRT-PCR assay
with custom TaqMan small RNA probes. The data dem-
onstrate that the longest spacer tested (2500 bp) resulted
in the greatest change in target gene expression levels in
the presence and absence of ligand (Figure 2b). qRT-
PCR analysis showed that the decrease in target gene ex-
pression levels correlated with an increase in mature
miRNA levels, indicating that the observed changes in
target gene expression levels were due to miRNA silen-
cing (Figure 2c). The OFF state (i.e., expression level in
the presence of theophylline) measured for all constructs
is similar to that from the inactive ribozyme control
construct, which sets the expected lower limit for the
system (Figure 2b). The ON state (i.e., expression level
in the absence of theophylline) generally increased with
spacer length, consistent with previous findings in the
literature [19]. Overall, the device with the longest
spacer length tested (2500 bp) exhibited ON and OFF
states very close to the controls (Figure 2b, Additional
file 1: Figure S2), indicating that this device was acces-
sing nearly the full potential dynamic range of the sys-
tem. The data indicate that longer spacer lengths may
increase the time between transcription of the ribozyme
Figure 2 The effect of different spacer lengths on performance of the RNAi-based OFF control device. (a) Schematic of the expression cassettes used
to test the OFF control device architecture. A theophylline-responsive ribozyme switch was placed at various distances upstream of a miRNA targeting
GFP. GFP was expressed constitutively under a separate expression cassette. Both constructs were stably integrated into an HEK293 Flp-In cell line.
(b) GFP expression in the absence and presence of theophylline from OFF control devices with varying spacer lengths. GFP levels were measured
48 hours after the addition of 0 or 5 mM theophylline. No miR and miRNA only represent constructs with a theophylline-responsive ribozyme switch
and no downstream miRNAs (negative control) and a construct with miRNA only upstream of a GFP-targeting miRNA (positive control), respectively.
Data is reported as the percent of GFP expression in a cell line with no miRNA present. Error bars represent ±1 standard deviation of at least three
independent experiments. (c) Relative increase in miRNA levels after addition of theophylline. Relative miRNA levels are reported 48 hours after the
addition of 0 or 5 mM theophylline and normalized to the miRNA levels measured from identical cell lines in the presence of theophylline. Error bars
represent ±1 standard deviation of three independent experiments.
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component, thus increasing the probability that the ribo-
zyme will cleave and abort transcription [19] prior to the
transcription and processing of the miRNA.
A computational model informs the design of the
RNAi-based OFF control device
We developed a mathematical model to inform the design
of the RNAi-based OFF control device to elucidate im-
portant system design parameters. The model describes
the kinetics of ribozyme cleavage and miRNA formation
using a series of differential equations describing the sep-
arate processes (Additional file 1: Figure S3, Additional file
1: Text S1). The transcription of the ribozyme-miRNA
transcript is modeled as a two-step process in which an“immature transcript”, harboring only the ribozyme com-
ponent, is initially formed. This immature transcript is ei-
ther cleaved and subsequently degraded or elongated into
a full-length transcript, encoding both the ribozyme and
miRNA components. Mature miRNAs are formed from
the full-length transcript and subsequently silence target
gene expression through enzymatic degradation using a
term that resembles traditional Michaelis-Menten kinet-
ics, which includes a constant (Km) describing the affinity
between the miRNA and the target transcript [22]. The
presence of the input ligand will lower the ribozyme cleav-
age rate, resulting in an increase in the level of full-length
transcript and thus increased miRNA levels. The binding
kinetics between the aptamer and the ligand (ka, kd) as
well as the cleavage rates of the ribozyme when bound
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measured experimentally [23,24]. The parameters that de-
termine the gene silencing at different miRNA levels (a,
Km) were determined previously [22]. All other model pa-
rameters were determined using parameter fitting soft-
ware in MATLAB by simulating the system of equations
and fitting the steady-state values to the experimental data
for the theophylline-responsive OFF control device.
We used the model to predict the effects of different pa-
rameters on device function and to identify where the
theophylline-responsive device fell in relation to these pre-
dictions. For example, the model predicts the quantitative
increase in the change in target expression level as a func-
tion of increasing spacer length that is observed in our ex-
perimental system (Figure 3a). We used the model to
interrogate the impact of miRNA-target gene affinity, Km,
on the performance of the OFF control device (Figure 3b).
The model predicts an optimal value of approximately
3500 nM, corresponding to the largest dynamic range
achievable by the OFF control device. At very high Km,
there is little target gene silencing from the miRNA, and
an increase in miRNA levels will lead to little difference in
target gene expression. At very low Km, a large amount of
miRNA silencing is observed even at low miRNA levels
that saturates as miRNA levels increase [22]. Our experi-
mental results indicate that the Km of the theophylline-
responsive control device is nearly optimal for the system
(Figure 3b). Finally, we used the model to interrogate the
impact of the ratio of cleavage rates between the ligand
unbound and bound ribozyme switch (kcleave/kcleave-bound)
on the performance of the OFF control device (Figure 3c).
As this ratio increases, the model predicts an increase in
the change in target gene expression levels in the presence
of the ligand. In our theophylline-responsive system, the
ratio of cleavage rates is approximately 5.6. The model
predicts that increasing this ratio would lead to substantial
increases in the change in target gene expression, indicat-
ing that this is a key parameter in the design of control de-
vices with specified dynamic ranges.Figure 3 Parameters that affect performance of the RNAi-based OFF contr
and the length of the spacer between the ribozyme switch and miRNA co
ratio of ribozyme cleavage rates in the absence and presence of ligand, kcl
results. Device dynamic range is reported as the percent change in GFP exThe model can be used to identify which components of
the circuit can be targeted for modification to optimize the
performance of the circuit. For example, both spacer length
and the ratio of ribozyme cleavage rates in the presence
and absence of the ligand (kcleave/kcleave-bound) were found to
be critical parameters in tuning the dynamic range of the
OFF control device. High-throughput screening strategies
have been described that support efficient tuning of the
cleavage rates of ribozyme switches [25]. As another
example, the model indicated that miRNA silencing effi-
ciency, largely determined by Km, determines the silencing
observed at a given miRNA level. The Km of a miRNA-
target gene pair can be modified by incorporating add-
itional target sites into the 3′ untranslated region (UTR) of
the target transcript [22,26]. With the components selected
for this study, the systems were limited to dynamic ranges
on the order of ~2-fold. While this regulatory activity is
on the order of that observed with endogenous miRNA
regulatory networks [27], it is lower than many synthetic
transcription-based control systems in use. Improvements
in the properties of the underlying device components
(i.e., ribozyme switch, miRNA) will allow for OFF control
devices with improved dynamic ranges supporting broader
applications.
Protein-responsive RNAi-based OFF control devices
To adapt the RNAi-based OFF control devices to respond
to proteins, we replaced the small molecule-responsive
ribozyme switch with ribozymes that alter their cleavage
activity in the presence of specified protein ligands. The
modular nature of the ribozyme switch platform allowed
us to tailor the ligand responsiveness of the switch by
swapping new aptamer sequences into the sensor domain
of the platform [20].
We developed protein-responsive ribozyme switches to
two protein ligands: the MS2 bacteriophage coat protein
(MS2) and an oncogene (E2F1). Specifically, sequences for
previously characterized RNA aptamers to MS2 [28] and
E2F1 [29] were placed directly into the sensor domain ofol device. (a-c) Predicted relationships between device dynamic range
mponents (a), miRNA-target transcript binding affinity, Km (b), and the
eave/kcleave-bound (c). Grey line: model predictions; circle: experimental
pression in the absence and presence of theophylline.
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terized transmitter sequence [25]. The binding and cleav-
age activities of the MS2- and E2F1-responsive ribozyme
switches were characterized using previously described
in vitro assays. The binding activities of the switches were
measured using a surface plasmon resonance assay on a
Biacore instrument [23]. The results of this binding assay
indicate that the protein-responsive switches bind their
cognate ligands with high affinities; the MS2-responsive
switch has a KD of 296 nM [30] and the E2F1-responsive
switch has a KD of 548 nM (Additional file 1: Figure S4a).
The cleavage rate of the MS2-responsive switch was mea-
sured using a gel-based cleavage assay [23]. The results of
the cleavage assay demonstrate that the MS2 ligand
substantially affected the cleavage rate of the ribozyme
switch, resulting in an approximate 2.5-fold decrease in
cleavage rate in the presence of 2 μM MS2 [30]. End point
cleavage assays were similarly performed on the E2F1-
responsive switch and confirmed that the presence of lig-
and decreased the cleavage activity of this ribozyme switch
(Additional file 1: Figure S4b, c). Taken together, the data
indicate that the protein-responsive ribozyme switches
bind their cognate ligands with high affinities and in a
manner that disrupts cleavage activity of the ribozyme.
The validated protein-responsive ribozyme switches
were placed into the OFF control device platform to build
an RNAi-based control system that decreased target gene
expression levels as a function of increasing MS2 and
E2F1 levels. Expression cassettes were constructed with
the protein-responsive ribozymes placed 2500 bp up-
stream of a GFP-targeting miRNA (Figure 4a). A second
expression cassette was constructed that encoded the
expression of a GFP fluorescent reporter protein. Isogenic
cell lines stably expressing both expression cassettes were
generated from a Flp-In HEK293 cell line as previously
described.
Device performance was quantified by measuring target
protein (GFP) and mature miRNA levels in the presence
and absence of the protein ligands as previously described
(Figure 4b-e). Plasmids expressing MS2 or E2F1 were tran-
siently transfected into the stable cell lines expressing the
MS2- or E2F1-responsive OFF control devices, respectively,
and compared to the identical stable cell line transfected
with a mock plasmid (i.e., no protein ligand expressed).
The data demonstrate that GFP expression levels are re-
duced up to 2.1- and 1.8-fold in response to MS2 and E2F1
expression, respectively (Figure 4b,c). As with the
theophylline-responsive OFF control device, the OFF states
of the protein-responsive devices are similar to the positive
control (i.e., miRNA only). When taking into account the
differences in cleavage rates (kcleave/kcleave-bound) between
the protein-responsive ribozymes and the theophylline-
responsive ribozyme, with no additional refitting of other
parameters, the model predicts the observed difference ingene-regulatory activities of the devices (Figure 4d). Larger
changes in target gene expression correlated with larger
cleavage rate ratios in the presence and absence of ligand,
supporting that the cleavage rate ratio is a key design par-
ameter for these systems. The qRT-PCR analysis indicated
that the increase in GFP silencing was due to an increase in
the levels of mature miRNAs within the cells (Figure 4e).
Taken together, these results indicate that OFF control de-
vices can be constructed to respond to a variety of ligands
by integrating ribozyme switches that respond to the li-
gands of interest.
Protein-responsive RNAi-based OFF control devices
support the implementation of negative feedback control
systems
Feedback regulation is ubiquitous in biology and funda-
mental to many engineering applications. Synthetic biolo-
gists have designed a wide range of engineered biological
transcriptional feedback regulation systems [31,32]. Nega-
tive and positive transcriptional feedback controllers have
been used to stabilize desired output protein concentra-
tions, accelerate system dynamics, and generate biological
oscillations [33-35]. However, engineered genetic negative
feedback control systems have been used to regulate the
expression of transgenes; a system has not been developed
that can exert feedback control over endogenous genes.
This expanded capability would be a powerful tool to en-
gineer synthetic circuits to maintain desired cell pheno-
types, for example, in the presence of genetic mutations
or fluctuating levels of signaling molecules or cytokines.
The RNAi-based OFF control device has the ability to
regulate the levels of a target protein around a desired set
point by enabling the implementation of a negative feed-
back control system in mammalian cells (Additional file 1:
Text S1). In this system design, a ribozyme switch respon-
sive to a protein of interest and a miRNA that targets that
same protein of interest are integrated into the OFF con-
trol device architecture. Thus, an increase in levels of the
input protein will result in an increase in levels of the
miRNA, which will subsequently reduce levels of the pro-
tein to the desired set point level.
We first adapted our model to capture the behavior of a
negative feedback system based on our protein-responsive
OFF control device (Additional file 1: Text S1). In the
negative feedback system model, the input is the max-
imum level of target gene expression, the output is the tar-
get protein levels, and our control action, or miRNA
levels, regulates the ratio of output to input levels such
that target protein expression remains relatively consistent
independent of input level. In order to capture the behav-
ior of a feedback control system which regulates levels of
MS2-DsRed fusion protein, we included the parameters
for the cleavage rate of the MS2-responsive ribozyme and
a DsRed-targeting miRNA in the model (Additional file 1:
Figure 4 Protein-responsive RNAi-based OFF control devices. (a) Schematic overview of the genetic circuit used to characterize protein-responsive
OFF control devices. The OFF control devices and GFP were stably integrated and expressed from identical expression cassettes as described in
Figure 2a, except that the theophylline-responsive ribozyme was replaced with an MS2- or E2F1-responsive ribozyme switch. A plasmid encoding the
expression of DsRed only (mock plasmid) or the protein ligand (MS2 or E2F1) was transfected into the cell lines to measure activity of the OFF control
device. (b-c) GFP expression levels under the control of the MS2-responsive (b) or E2F1-responsive (c) OFF control device. No miR and miRNA only
represent constructs with a protein-responsive ribozyme switch and no downstream miRNAs (negative control) and a construct with a non-cleaving
ribozyme upstream of a GFP-targeting miRNA (positive control), respectively. Error bars represent ±1 standard deviation of at least three independent
experiments. (d) Device dynamic ranges for the OFF control devices as a function of the ratio of cleavage rates (kcleave/kcleave-bound). Grey line: model;
circle: theophylline-responsive device; square: MS2-responsive device. Device dynamic range is reported as the percent change in GFP expression in
the absence and presence of theophylline. (e) Relative increase in miRNA levels after addition of protein ligand. Relative miRNA levels are reported
normalized to the miRNA levels measured from identical cell lines in the absence of protein ligand. Error bars represent ±1 standard deviation of three
independent experiments.
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levels) directly affects miRNA levels, and therefore at
higher MS2-DsRed levels, the increase in miRNA levels
will decrease levels of MS2-DsRed protein. The model
predicts that in the parameter ranges observed experimen-
tally the OFF control device exerts proportional control
(P-control) over the protein of interest. Unlike in an inte-
gral controller, the output from P-type controllers is not
independent of the input, but rather exhibits an offset
from the desired set point. The result is that the level of
our protein of interest (output) will increase linearly as the
maximum level (input) increases (Figure 5a). Consistent
with observations of feedback control in biological sys-
tems [18], the model predicts that the offset will decrease
as the degradation of the miRNA depends less on theconcentration of the miRNA. If the degradation of the
miRNA is a constant rate such that it does not rely on the
concentration of miRNA, then ‘perfect adaptation’ or inte-
gral control will be achieved. Integral control is character-
ized by no offset and the steady-state output protein levels
are stable at a constant level, regardless of the input level
(Figure 5b).
We examined the model predictions in our experi-
mental system by modifying the OFF control device to
exhibit negative feedback around the levels of the MS2
protein (Figure 5c). An expression cassette was designed
in which the MS2-DsRed fusion protein was under the
transcriptional control of a doxycycline-inducible CMV-
TetO2 promoter and TetR transcriptional repressor pair.
In a separate expression cassette, the MS2-responsive
Figure 5 The protein-responsive OFF control device supports the design of a negative feedback control system over MS2 levels. (a) Model prediction for
MS2 feedback system where miRNA level (control action) is dependent upon the level of miRNA in the cell. The output (MS2 protein) levels are shown
plotted as a function of the input (maximum MS2) levels. (b) Model prediction for the MS2 system where the miRNA level (control action) is independent
of the levels of miRNA. The output (MS2 protein) levels are shown plotted as a function of the input (maximum MS2) levels. (c) Schematic of the circuit
used to test the MS2-responsive OFF control device exerting feedback control over MS2 levels. A doxycycline-responsive CMV-TetO2 promoter was used
to control the expression of an MS2-DsRed fusion protein. An OFF control device containing an MS2-responsive ribozyme switch and a miRNA targeting
DsRed were expressed in a separate expression cassette under the control of a constitutive promoter (PCMV). The expression cassettes are stably integrated
into a Flp-In HEK293 T-REx cell line, which expresses the TetR repressor. Input levels (maximum MS2-DsRed levels) were varied by growing the cells under
different concentrations of doxycycline. The input is highlighted in red, the output (MS2-DsRed levels) is highlighted in blue, and the control action
(miRNA levels) is highlighted in yellow. (d) Output (MS2-DsRed) levels as a function of the input (maximum MS2-DsRed transcript) levels for circuits with
and without a feedback controller. The output and input are reported as the percent of the maximum DsRed levels in a cell line with no miRNA present.
Error bars represent the standard deviation of three independent experiments. (e) The slope as a function of the input. The local slope is calculated as:
Slopei = (Outputi – Outputi-1) /(Inputi – Inputi-1).
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targeting miRNA component was replaced with a DsRed-
targeting miRNA. In this negative feedback system design,
the MS2-DsRed protein levels serve as the system output.
As the output levels increase, the MS2 will trigger the for-
mation of miRNAs that target the coding region of DsRed,
thereby acting to reduce the levels of MS2-DsRed and
serving as a form of negative feedback control. Isogenic
cell lines stably expressing both expression cassettes were
generated from a Flp-In HEK293 T-REx cell line as previ-
ously described. The Flp-In HEK293 T-REx cell line also
stably expresses the TetR transcriptional repressor, such
that the maximum level of MS2-DsRed (the input) is
tightly regulated by the concentration of doxycycline in
the media. In particular, the levels of MS2-DsRed were
held low prior to induction and measurements were made
48 hours after induction, such that differences in the half
lives of d2EGFP and MS2-DsRed (2 hours [36] versus
8 hours [37], respectively) would not affect the experimen-
tal results.
The resulting stable cell lines were used to characterize
the activity of the negative feedback control device regulat-
ing MS2 levels (Figure 5c). DsRed levels were used as the
output from the feedback system and were measured using
a flow cytometry assay, the input (maximum MS2-DsRed
level) was controlled using a doxycycline-responsive indu-
cible promoter. Our data show that, compared to a system
with no feedback control, there is a significant reduction in
the levels of MS2 protein as the transcription rate is
increased (Figure 5d). The local slope was also calculated as:
Slopei = (Outputi – Outputi-1) /(Inputi – Inputi-1) (Figure 5e).
Our experimental system (Figure 5d, e) exhibits similar
behavior to that predicted of a proportional controller
(Figure 5b) in that the output is not independent of the in-
put, but rather linearly increases as the input increases. Our
results highlight that the RNAi-based OFF control device
platform can be used to effectively exert feedback control
over the levels of a protein of interest.
While there are several examples of negative feedback
being implemented in synthetic circuits to alter the
dynamics of the circuit [34,38], as well as in the construc-
tion of oscillators [33] and toggle switches [39], the
described control systems do not have the ability to exert
feedback control over endogenous genes. Our RNAi-based
feedback control system behaves as a proportional controller
(P-controller), where the control action (miRNA level) is
proportional to the output (protein level). To implement in-
tegral feedback control the control action (miRNA level)
must be solely a function of the output (protein level). Our
model indicates that perfect adaptation cannot be achieved
in our system as the miRNA degradation rate is a linear
function of the miRNA level. Maintaining miRNA degrad-
ation at a constant level would allow us to achieve perfect
adaptation [18]. However, in practice, keeping the rate ofchange of a molecular species independent of its own level
through zeroth-order degradation kinetics is difficult to
achieve in cellular systems, where molecular concentrations
are governed by biochemical kinetics. Any mechanisms
working to decrease the concentration of the control action
species will likely need to operate at saturation with respect
to the control action species in order to achieve zeroth order
degradation kinetics. It is likely that many biological feed-
back systems operate using proportional control and may
need to incorporate additional redundancies in cases where
maintaining the level of a molecule within a narrow concen-
tration range is critical.
Conclusions
Our work describes a novel genetic device that increases
the level of silencing from a miRNA in the presence of a
ligand of interest, effectively creating an RNAi-based OFF
control device. Our OFF control device incorporates a
ligand-responsive ribozyme and spacer element upstream
of a miRNA regulator within the same expression cassette
such that co-transcriptional cleavage of the ribozyme aborts
transcription and prevents pri-miRNA formation. In the
presence of ligand, the cleavage rate of the ribozyme is re-
duced, resulting in accumulation of pri-miRNA transcripts,
which are subsequently processed into mature miRNAs
that silence the target gene. Similar to previous designs
[40], this coupled architecture allows the miRNA regulator
to act as a genetic inverter, by inverting the signal from the
ON ribozyme switch to an OFF genetic switch. We demon-
strated the flexibility of the OFF switch platform by show-
ing that it can be used to respond to both small molecule
and protein ligands and developed a computational model
describing the device that revealed important design
parameters and parameter ranges associated with optimal
performance of the control device. Finally, we used the
RNAi-based OFF switch to implement a negative feedback
control system, that maintained target intracellular protein
levels in response to increases in transcription rate.
Our computational model revealed important design
parameters and parameter ranges associated with opti-
mal performance of these control devices. Thus, the
model can be used to guide careful selection or tuning
of components and/or inform how different parameters
would impact the quantitative behavior of the control
device. For example, the model identified spacer length,
ribozyme cleavage rates in the presence and absence of
ligand, and miRNA silencing efficiency as key parame-
ters in the design of OFF RNAi-based control devices.
With the components selected for this study, the sys-
tems were limited to dynamic ranges on the order of ~2-
fold. While this regulatory activity is on the order of that
observed with endogenous miRNA regulatory networks
[27], improvements to these activities will increase the
broader utility of these devices in synthetic contexts.
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OFF RNAi-based control devices can be achieved through
refinement of the underlying device components (i.e.,
ribozyme switch, miRNA).
By leveraging an RNAi-based regulatory mechanism, the
described OFF control device can be adapted to exert nega-
tive feedback control over endogenous gene targets. The
described control platform can be used in future cellular
engineering and gene therapy applications, where the ex-
pression of key genes can be kept at desired levels even in
the presence of cellular mutations or malfunctioning signal-
ing pathways. Further development and optimization of the
ribozyme switch and miRNA components will enable re-
searchers to extend this platform for implementation into
applications in health and medicine.
Methods
Plasmid construction
Modern molecular biology techniques were used to cre-
ate the plasmids and cell lines used in this work. A
chemically-competent Escherichia coli strain TOP10 was
used for cloning purposes (Life Technologies, Carlsbad,
CA) and was grown in LB medium (Becton, Dickinson
and Company (BD), Franklin Lakes, NJ) with the indi-
cated antibiotic concentrations. Custom oligonucleotides
were synthesized by Integrated DNA Technologies (IDT,
Coralville, IA) and the Stanford Protein and Nucleic
Acid Facility (PAN, Stanford, CA). PCR was performed
with Taq polymerase (New England Biolabs, Ipswich,
MA) for products less than 1 kb and Pfu Ultra II Hot-
start (Agilent Technologies, Santa Clara, CA) for prod-
ucts greater than 1 kb. All restriction enzymes were
obtained from New England Biolabs. Plasmids were pre-
pared from E. coli using Econospin columns (Epoch Life
Science, Missouri City, TX) according to manufacturer’s
instructions. Sequencing was performed by Elim Bio-
pharmaceuticals, Inc (Hayward, CA).
The plasmid pCS2304 was constructed by PCR amplify-
ing a DNA fragment encoding a CMV promoter, d2EGFP
coding sequence, the BGH-polyA tail, using the primers
BglII CMV Fwd (5′-AATAAGATCTTAGTTATTAATA
GTAATCAATTACGGGGTCATTAGT-3′) and Mfe bgh
Rev (5′-TATTCAATTGTTTGCTGTTTCGTCCTCCG-
3′) and cloning the fragment between the BglII and MfeI
restriction sites in pcDNA5/FRT. Spacer regions of different
lengths were PCR amplified from the LacZ gene using the
primers BstBi-Xma-mid LacZ Fwd: (5′-ATATTCGAAAA
TACCCGGGA TACTGTCGTCGTCCCCT-3′) and 500
bp LacZ rev (5′-AATAGGTACCATCGATAAT AACCG
GTGTGTAGATGGGCGCATCG-3′) for the 500 bp spa-
cer, 1000 bp LacZ rev (5′-AATAGGTACCATCGATAA
TAACCGGTTTG GCCCTGTCAGAAATCCAGGGG-3′)
for the 1000 bp spacer, and 2500 bp LacZ rev (5′-AA
TAGGTACCATCGATAATAACCGGTAAGCGCTGTCACCGGAATCAA-3′) for the 2500 bp spacer. These
fragments were subsequently digested with BstBI and
BamHI and cloned between the BstBI and BamHI re-
striction sites in the above intermediate plasmid to cre-
ate pCS2722 (Additional file 1: Figure S5). The Rev
primers used for amplifying the spacer incorporated
AgeI and ClaI restriction sites on the 3′ end of the spa-
cer, which were used for miRNA cloning in downstream
steps. The resulting plasmids include two expression
cassettes, one that drives the expression of d2EGFP and
one that drives expression of different spacers that in-
clude restrictions sites on the 5′ end (BstBI, XmaI) and
3′ end (AgeI, ClaI) and is the base plasmid which was
used in all OFF control switch studies in this work. The
BstBI and XmaI restriction sites were used to clone the
ribozyme switches and associated controls, and the AgeI
and ClaI restriction sites were used to clone the miR-
NAs and associated controls. Finally, the plasmid con-
tains FRT recombinase sites for making stable cell lines
with the FLP recombinase system (Life Technologies).
We constructed pCS2934 (Additional file 1: Figure S5),
which encodes MS2-DsRed expression under the control of
an inducible promoter. A DNA fragment encoding CMV-
TetO2-MS2-DsRed was obtained by digesting pCS2892
[22] with BglII and AvrII, and purifying the 1800 bp
fragment by gel extraction. The backbone pCS2722 was
digested with BglII and AvrII and the two DNA fragments
were ligated together to form pCS2934, which includes an
expression cassette encoding the expression of an OFF con-
trol device downstream of a cassette which encodes the ex-
pression of the MS2-DsRed fusion gene driven by the
CMV-TetO2 promoter. A detailed list of all plasmids used
in this work is contained in Additional file 1: Table S2.
For the construction of all OFF control devices, the miR-
NAs were cloned downstream of the spacer region using
the AgeI and ClaI restriction sites. The ribozyme switches
and controls were cloned upstream of the spacer region
using the BstBI and XmaI restriction sites. All miRNA and
ribozyme components were constructed by ordering two
ultramer oligonucleotides (Integrated DNA Technologies),
which were reverse complements of each other at their 3′
ends. The oligonucleotide pairs were subjected to five
rounds of annealing and extension using Taq polymerase
(New England Biolabs) in a thermocycler. The resulting
DNA fragments were subsequently digested and cloned.
The sequences of all miRNAs and ribozymes used in this
study are presented in Additional file 1: Table S3.
Mammalian cell culture
HEK293 Flp-In T-REx cells (Life Technologies) were
maintained in DMEM supplemented with 10% FBS at
37°C in a 5% CO2-humidified incubator. Stable transfection
of HEK293 Flp-In T-REx cell lines was performed using the
Flp-In recombinase system (Life Technologies) according to
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cell lines. Stable integrants were selected using 200 μg/ml
hygromycin B (Life Technologies), whereas stable cell lines
were maintained in 100 μg/ml hygromycin B.
Measuring fluorescent reporter expression through flow
cytometry assays
miRNA induction experiments were performed by first
seeding 24-well cell culture plates with stable cell lines at
2.5×105 cells per well. After 48 hours, cells were trypsi-
nized and subjected to flow cytometry analysis on a Cell
Lab Quanta SC MPL (Beckman Coulter, Brea, CA), and
the resulting data were analyzed using the FlowJo software
(Tree Star, Ashland, OR). For experiments utilizing doxy-
cycline induction, fresh media containing 0, 0.05, 0.2, 0.8,
3.2, or 50 ng/mL doxycycline was added to the wells
24 hours after seeding and measured by flow cytometry as
described above. Cells were initially gated for viability by
electronic volume and side scatter. GFP and DsRed fluor-
escence of viable cells were measured through 525- and
670-nm bandpass filters, respectively, after excitation with
a 488-nm laser. The levels of the fluorescent reporters
were calculated as the median fluorescence of the stable
cell population (Additional file 1: Figure S6). All fluores-
cent reporter levels were normalized to the corresponding
fluorescent reporter level from cells harboring a control
construct lacking a miRNA under the same conditions. At
least two biological replicates were included in each ex-
periment, and reported data are the averages of at least
three independent experiments. Error bars represent ±1
standard deviation.
Measuring miRNA levels through Taqman assays
The levels of miRNAs in the cells were quantified using
custom Taqman small RNA assays (Applied Biosystems,
Carlsbad, CA) according to the manufacturer’s instructions.
Cells at different experimental conditions were plated in
duplicate in 96-well tissue culture plates at a concentration
of 10,000 cells per well. After 48 hours, the cells in one well
were trypsinized and counted in a hemocytometer to obtain
an accurate count of the number of cells per well for each
experimental condition. The cells in the remaining well
were lysed by adding 50 μl of Taqman lysis buffer and incu-
bating for 8 minutes. The lysis reaction was stopped with
the addition of 5 μl of stop buffer, resulting in a total
volume of 55 μl of lysate per sample. A fixed volume of 5 μl
of this lysate was used as input into the reverse transcrip-
tion (RT) reaction.
Input RNA was reverse transcribed using the TaqMan
miRNA Reverse Transcription Kit and custom miRNA-
specific stem-loop primers (Applied BioSystems) in a
small-scale RT reaction (1.387 μl of H2O, 0.5 μl of 10X
reverse transcription buffer, 0.063 μl of RNase inhibitor
(20 units/μl), 0.05 μl of 100 mM dNTPs with dTTP,0.33 μl of multiscribe reverse transcriptase, 1.67 μl of in-
put RNA; components other than the input RNA were
prepared as a larger volume master mix). The reaction
was run on an iCycler iQ system (BioRAD, Hercules,
CA) at 16°C for 30 min, 42°C for 30 min, and 85°C for
5 min. The RNU 6B Taqman miRNA control was used
to normalize the Ct values of the experimental miRNAs and
to confirm the cell quantities measured by hemocytometer
counting. Real-time PCR was carried out on an iCycler iQ
thermocycler (BioRAD) at 95°C for 10 minutes, followed by
40 cycles of 95°C for 15 seconds and 60°C for 1 minute. The
Ct was calculated using available RT-PCR Miner software
[41], which automatically detects Ct and efficiency values for
each PCR reaction. The mean of the resulting Ct values for
the target gene of each sample were subtracted from the
mean Ct value for the control gene. The resulting values
were then converted from log2 to linear scale and normal-
ized to the value from the sample lacking any miRNA with
the same concentration of ligand.
Measuring binding properties between ribozyme switches
and protein ligands
The binding properties between the protein-responsive
ribozyme switches or RNA aptamers and the correspond-
ing protein ligands (i.e., MS2, E2F1) were determined
according to previously described methods [24]. Briefly,
ribozyme switches, aptamers, and appropriate controls
were transcribed from DNA templates using the MEGA-
shortscript T7 kit (Life Technologies) and purification of
the transcription products was performed using the RNA
Clean & Concentrator Kit (Zymo Research) according to
the manufacturers’ instructions. In all experiments, the
HBS-N running buffer (GE Healthcare) (10 mM HEPES,
150 mM NaCl, pH 7.4) was used with no MgCl2 present,
to prevent cleavage of the ribozyme. A dilution series of
the target was prepared in running buffer using a mini-
mum of five concentrations for kinetic analysis. For each
sample concentration, the ribozyme switch was captured
onto the sample flow cell (FC2) for 30 seconds at a flow
rate of 10 μL/minute, the target solution was injected over
both flow cells at a flow rate of 30 μL/minute to monitor
target association, and running buffer was injected over
both flow cells at a flow rate of 30 μL/minute to monitor
target dissociation.
Data processing and analysis were performed using
Biacore X100 Evaluation Software version 2.0 (GE Health-
care, San Francisco, CA). A double-referencing method
was performed to process all datasets [42,43]. Data from
the sample flow cell (FC2) were referenced first by subtract-
ing data from the reference flow cell (FC1) to correct for
bulk refractive index changes, nonspecific binding, injection
noise, matrix effects, and baseline drift. The reference-
subtracted data (FC2-FC1) were double-referenced with a
blank injection of running buffer to account for any
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double-referenced data were fit to a 1:1 binding model for
kinetic analysis to calculate the ka and kd between the
ribozyme and the protein. The overall dissociation con-
stant, KD, was calculated from ka, and kd.
Gel-based ribozyme cleavage assays
Gel-based ribozyme cleavage assays were performed as
previously described [23]. Briefly, all gel-based ribozyme
cleavage assays were performed in a physiologically rele-
vant reaction buffer (50 μl) composed of 500 μM MgCl2,
100 mM NaCl, and 50 mM Tris–HCl (pH 7.5) at 37°C. A
12-nt RNA blocking sequence that is complementary to
part of the ribozyme transcript was inserted at the 5′ end
of the sTRSV HHRz transcript to generate a cis-blocked
ribozyme construct. In the reaction volume, 75 nM of
full-length RNA was first incubated with 2.5 μM DNA ac-
tivator strand (5′-AAACAACTTTGTTTGTTTCCCCC-
3′), which is ordered from Integrated DNA Technologies
as an oligonucleotide with standard desalting, for 2 min to
activate the blocked RNA. A zero time-point aliquot was
taken before initiating the self-cleavage reaction with the
addition of MgCl2 and the indicated concentration of in-
put protein. Reactions were quenched after 20 min with
addition of 3 volumes of RNA stop/load buffer (95% form-
amide, 30 mM EDTA, 0.25% bromophenol blue, 0.25% xy-
lene cyanol) and placed on ice. Samples were heated to
95°C for 5 min, snap cooled on ice for 5 min, and size-
fractionated on a denaturing (8.3 M urea) 10% polyacryl-
amide gel at 25 W for 45–60 min. Gels were exposed
overnight on a phosphor screen and imaged on a FX Mo-
lecular Imager (BioRAD). The relative levels of the full-
length transcript and cleaved products were determined
by phosphorimaging analysis.
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